BRD2 and primary ovarian failure: In this case–control study, which comprised 169 women with primary ovarian failure and 209 healthy women, the authors monitored follicle-stimulating hormone (FSH), luteinizing hormone (LH), anti-Mullerian hormone (AMH), and estradiol.